Figure 2.
Figure 2. Schema for E4402/CTSU E4402, “Randomized Phase III Trial Comparing Two Different Rituximab Dosing Regimens for Patients with Low Tumor Burden Indolent Non-Hodgkin’s Lymphoma.”. / Abbreviations: R, rituximab; CR, complete response; PR, partial response; PD, progressive disease

Schema for E4402/CTSU E4402, “Randomized Phase III Trial Comparing Two Different Rituximab Dosing Regimens for Patients with Low Tumor Burden Indolent Non-Hodgkin’s Lymphoma.”

Abbreviations: R, rituximab; CR, complete response; PR, partial response; PD, progressive disease

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal